In the outpatient setting, has the administration of doxorubicin IVP recently changed at anyone's facilities? For regimens such AC, CHOP or ABVD, do you administer doxorubicin IV push or IVPB? If you administer doxorubicin IVPB via a central venous access device, how often do you check blood return and do you have a nursing policy in place for IVPB administration of vesicant chemotherapy agents versus IV push which clearly states the requirements for venous access in each case IVP vs IVPB? Currently, the facility I am employed at wants to standardize the administration of doxorubicin to IVPB for all regimens whether inpatient or outpatient. I understand that inpatient protocols such as EPOCH and Hyper CVAD have CIV doxorubicin that requires to be administered via IVPB but is a much more diluted dose and dripping slowly over 24 hours. However, for outpatient protocol where doxorubicin is bolus, I'm not seeing the rationale. Any impute would be greatly appreciated. Thanks!
------------------------------
Rosamari Douglas RN BSN OCN
Oncology / Infusion RN
Beaumont Health
Clinton Township MI
------------------------------